What is ILC?
This course provides a comprehensive overview of the field, including the latest advances, key players, and potential risks and rewards which developed by a multidisciplinary core team and key scientists as well as key opinion leaders in those fields.
Designed for venture capitalists, pharma executives, biotechnology professionals, and anyone interested in longevity tech investment.
Course Highlights:
- Core Lectures from experts in the field
- Supplementary material slides and notes
- Quizzes to track your progress
- Certificate of completion
- Opportunity to connect with key opinion leaders
What Will I Learn?
-
Insights into the science, medicine, technology, and economics of aging, essential for longevity investing, giving you a competitive edge.
-
Promising areas for investment, focusing on companies, clinics, and institutes involved in longevity science, medicine, and technology.
-
Strategies to understand and minimize the potential risks associated with longevity investments.
-
How to invest in companies and technologies working towards improving human health and extending lifespan, making a positive societal impact.
Requirements & Prerequisites
-
Longevity Medicine 101 Course
-
Longevity Medicine 201 Course (recommended)
Course Curriculum
Investing in Longevity Course (ILC)
Available in
days
days
after you enroll
Getting Started!
Available in
days
days
after you enroll
Course Introduction
Available in
days
days
after you enroll
Investing in Longevity
Available in
days
days
after you enroll
Pharma Companies and Longevity Therapeutics
Available in
days
days
after you enroll
Final
Available in
days
days
after you enroll
Course Completion Certificate
The certificate will be automatically available for print or download after successful completion of the course and passing the final assessment.
Alex Zhavoronkov, PhD
Evelyne Bischof, MD, PhD
Phil Newman
Ricardo Gaminha Pacheco, MD, MBA